Rewind Therapeutics Builds Stronger Advisory Board with Neurology Experts for Remyelination Therapy Rewind Therapeutics has added four esteemed neurologists to its Scientific Advisory Board, enhancing its capabilities as it moves forward with its groundbreaking GPR17 remyelination therapy aimed at neurological disorders.

Rewind Therapeutics Builds Stronger Advisory Board with Neurology Experts for Remyelination Therapy #Belgium #Leuven #Rewind_Therapeutics #GPR17 #Remyelination